[Current possibilities in the treatment of high-malignity non-Hodgkin lymphoma, with special reference to autologous hematopoietic stem cell transplantation].

Abstract

The present combined radiochemotherapy results in a complete remission in 50-60 percent of patients suffering from high-grade non-Hodgkin's lymphoma but only about half of them are cured. The basic regimen for chemotherapy is still the CHOP. There are known "salvage"-protocols, among them the CEPP-regimen, for patients who relapsed. For the still… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.